Xicheng, Hebei, China HOPU Investment Management Company appeared to be the Corporate Investor, which was created in 2008. The company was established in Asia in China. The leading representative office of defined Corporate Investor is situated in the Xicheng.
For fund there is a match between the location of its establishment and the land of its numerous investments - China. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 3 or 5+ of the founder, the chance for it to get the investment is meager. Among the most successful fund investment fields, there are Pharmaceutical, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Xiaomi, NIO, SenseTime. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the HOPU Investment Management Company, startups are often financed by Global Logistic Properties, Venrock, Qiming Venture Partners. The meaningful sponsors for the fund in investment in the same round are Hillhouse Capital Group, YuanMing Capital, Tiger Global Management. In the next rounds fund is usually obtained by Tencent Holdings, Baillie Gifford, YuanMing Capital.
The fund was created by Fenglei Fang.
The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. When the investment is from HOPU Investment Management Company the average startup value is more than 1 billion dollars. This HOPU Investment Management Company works on 10 percentage points less the average amount of lead investments comparing to the other organizations. Considering the real fund results, this Corporate Investor is 11 percentage points more often commits exit comparing to other organizations. The fund is generally included in 2-6 deals every year. The increased amount of exits for fund were in 2018. Deals in the range of more than 100 millions dollars are the general things for fund.
Related Funds
Funds with similar focus
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
JingXi ZhiXing | $309M | 19 Jun 2023 | Zhangjiakou, Hebei, China | ||
Lyndra Therapeutics | $60M | 24 Jun 2021 | Watertown, Massachusetts, United States | ||
Lyndra Therapeutics | $60M | 11 Feb 2019 | Watertown, Massachusetts, United States | ||
Lianshang Literature | $20M | 26 Dec 2018 | Shanghai | ||
I-Mab Biopharma | $220M | 29 Jun 2018 | Shanghai | ||
SenseTime | $620M | 31 May 2018 | Dongcheng District, Beijing, China | ||
Yimidida | $79M | 25 Apr 2018 | Shanghai, China | ||
Wtoip | 06 Feb 2018 | Yuexiu District, Guangdong Province, China | |||
NIO | $316M | 21 Jul 2016 | Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
JingXi ZhiXing | $309M | 19 Jun 2023 | Zhangjiakou, Hebei, China | ||
Lyndra Therapeutics | $60M | 24 Jun 2021 | Watertown, Massachusetts, United States | ||
Lyndra Therapeutics | $60M | 11 Feb 2019 | Watertown, Massachusetts, United States | ||
Lianshang Literature | $20M | 26 Dec 2018 | Shanghai | ||
I-Mab Biopharma | $220M | 29 Jun 2018 | Shanghai | ||
SenseTime | $620M | 31 May 2018 | Dongcheng District, Beijing, China | ||
Yimidida | $79M | 25 Apr 2018 | Shanghai, China | ||
Wtoip | 06 Feb 2018 | Yuexiu District, Guangdong Province, China | |||
NIO | $316M | 21 Jul 2016 | Shanghai, China |
